Advertisement
Screener

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

PRESTIGE CONSUMER HEALTHCARE INC. Income Tax Expense

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Income Tax Expense of $9.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06

  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $9.36M, a 34.57% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $10.84M, a 54.50% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $15.12M, a 20.94% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $26.92M, a 55.74% increase year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for fiscal 2026 was $67.19M, a 3.43% decline from fiscal 2025.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for fiscal 2025 was $69.58M, a 4.35% increase from fiscal 2024.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for fiscal 2024 was $66.69M.
  • PRESTIGE CONSUMER HEALTHCARE INC. income tax expense (benefit) for fiscal 2023 was -$11.61M, a 120.34% decline from fiscal 2022.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 12 month
2026-06-30$9.36M
10-Q · filed 2026-08-06
$20.21M
derived: sum of 2 quarters · filed 2026-08-06
$35.33M
derived: sum of 3 quarters · filed 2026-08-06
$62.25M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$10.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$25.96M
derived: sum of 2 quarters · filed 2026-05-14
$52.88M
derived: sum of 3 quarters · filed 2026-05-14
$67.19M
10-K · filed 2026-05-14
2025-12-31$15.12M
10-Q · filed 2026-02-05
$42.04M
derived: sum of 2 quarters · filed 2026-02-05
$56.35M
10-Q · filed 2026-02-05
$80.18M
derived: sum of 4 quarters · filed 2026-08-06
2025-09-30$26.92M
10-Q · filed 2025-11-06
$41.23M
10-Q · filed 2025-11-06
$65.06M
derived: sum of 3 quarters · filed 2026-08-06
$84.19M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$14.31M
10-Q · filed 2026-08-06
$38.14M
derived: sum of 2 quarters · filed 2026-08-06
$57.26M
derived: sum of 3 quarters · filed 2026-08-06
$74.55M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$23.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$42.95M
derived: sum of 2 quarters · filed 2026-05-14
$60.24M
derived: sum of 3 quarters · filed 2026-05-14
$69.58M
10-K · filed 2026-05-14
2024-12-31$19.12M
10-Q · filed 2026-02-05
$36.41M
derived: sum of 2 quarters · filed 2026-02-05
$45.75M
10-Q · filed 2026-02-05
$63.62M
derived: sum of 4 quarters · filed 2026-05-14
2024-09-30$17.29M
10-Q · filed 2025-11-06
$26.63M
10-Q · filed 2025-11-06
$44.49M
derived: sum of 3 quarters · filed 2026-05-14
$61.02M
derived: sum of 4 quarters · filed 2026-05-14
2024-06-30$9.35M
10-Q · filed 2025-08-07
$27.21M
derived: sum of 2 quarters · filed 2026-05-14
$43.74M
derived: sum of 3 quarters · filed 2026-05-14
$60.59M
derived: sum of 4 quarters · filed 2026-05-14
2024-03-31$17.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$34.39M
derived: sum of 2 quarters · filed 2026-05-14
$51.25M
derived: sum of 3 quarters · filed 2026-05-14
$66.69M
10-K · filed 2026-05-14
2023-12-31$16.53M
10-Q · filed 2025-02-06
$33.38M
derived: sum of 2 quarters · filed 2025-02-06
$48.82M
10-Q · filed 2025-02-06
-$10.15M
derived: sum of 4 quarters · filed 2025-05-09
2023-09-30$16.86M
10-Q · filed 2024-11-07
$32.29M
10-Q · filed 2024-11-07
-$26.68M
derived: sum of 3 quarters · filed 2025-05-09
-$10.51M
derived: sum of 4 quarters · filed 2025-05-09
2023-06-30$15.44M
10-Q · filed 2024-08-08
-$43.53M
derived: sum of 2 quarters · filed 2025-05-09
-$27.37M
derived: sum of 3 quarters · filed 2025-05-09
-$11.80M
derived: sum of 4 quarters · filed 2025-05-09
2023-03-31-$58.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09
-$42.80M
derived: sum of 2 quarters · filed 2025-05-09
-$27.23M
derived: sum of 3 quarters · filed 2025-05-09
-$11.61M
10-K · filed 2025-05-09
2022-12-31$16.17M
10-Q · filed 2024-02-08
$31.74M
derived: sum of 2 quarters · filed 2024-02-08
$47.36M
10-Q · filed 2024-02-08
$56.24M
derived: sum of 4 quarters · filed 2024-05-15
2022-09-30$15.57M
10-Q · filed 2023-11-02
$31.20M
10-Q · filed 2023-11-02
$40.07M
derived: sum of 3 quarters · filed 2024-05-15
$55.35M
derived: sum of 4 quarters · filed 2024-05-15
2022-06-30$15.63M
10-Q · filed 2023-08-03
$24.50M
derived: sum of 2 quarters · filed 2024-05-15
$39.78M
derived: sum of 3 quarters · filed 2024-05-15
$54.09M
derived: sum of 4 quarters · filed 2024-05-15
2022-03-31$8.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15
$24.16M
derived: sum of 2 quarters · filed 2024-05-15
$38.46M
derived: sum of 3 quarters · filed 2024-05-15
$57.08M
10-K · filed 2024-05-15
2021-12-31$15.28M
10-Q · filed 2023-02-02
$29.58M
derived: sum of 2 quarters · filed 2023-02-02
$48.20M
10-Q · filed 2023-02-02
$53.06M
derived: sum of 4 quarters · filed 2023-05-05
2021-09-30$14.30M
10-Q · filed 2022-11-03
$32.92M
10-Q · filed 2022-11-03
$37.78M
derived: sum of 3 quarters · filed 2023-05-05
$50.58M
derived: sum of 4 quarters · filed 2023-05-05
2021-06-30$18.61M
10-Q · filed 2022-08-04
$23.47M
derived: sum of 2 quarters · filed 2023-05-05
$36.28M
derived: sum of 3 quarters · filed 2023-05-05
$43.58M
derived: sum of 4 quarters · filed 2023-05-05
2021-03-31$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05
$17.66M
derived: sum of 2 quarters · filed 2023-05-05
$24.97M
derived: sum of 3 quarters · filed 2023-05-05
$39.43M
10-K · filed 2023-05-05
2020-12-31$12.80M
10-Q · filed 2022-02-03
$20.11M
derived: sum of 2 quarters · filed 2022-02-03
$34.57M
10-Q · filed 2022-02-03
$48.06M
derived: sum of 4 quarters · filed 2022-02-03
2020-09-30$7.31M
10-Q · filed 2021-11-04
$21.77M
10-Q · filed 2021-11-04
$35.26M
derived: sum of 3 quarters · filed 2021-11-04
$47.75M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$14.46M
10-Q · filed 2021-08-05
$27.95M
derived: sum of 2 quarters · filed 2021-08-05
$40.45M
derived: sum of 3 quarters · filed 2021-08-05
$51.21M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$13.49M
10-K · filed 2020-05-08
$25.98M
derived: sum of 2 quarters · filed 2021-02-04
$36.74M
derived: sum of 3 quarters · filed 2021-02-04
$48.87M
10-K · filed 2022-05-06
2019-12-31$12.50M
10-Q · filed 2021-02-04
$23.26M
derived: sum of 2 quarters · filed 2021-02-04
$35.38M
10-Q · filed 2021-02-04
-$4.38M
derived: sum of 4 quarters · filed 2021-02-04
2019-09-30$10.76M
10-Q · filed 2020-11-05
$22.89M
10-Q · filed 2020-11-05
-$16.87M
derived: sum of 3 quarters · filed 2020-11-05
-$4.04M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$12.13M
10-Q · filed 2020-08-06
-$27.63M
derived: sum of 2 quarters · filed 2020-08-06
-$14.80M
derived: sum of 3 quarters · filed 2020-08-06
-$2.12M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$39.76M
10-K · filed 2020-05-08
-$26.93M
derived: sum of 2 quarters · filed 2020-05-08
-$14.25M
derived: sum of 3 quarters · filed 2020-05-08
-$2.25M
10-K · filed 2021-05-07
2018-12-31$12.83M
10-K · filed 2020-05-08
$25.51M
derived: sum of 2 quarters · filed 2020-05-08
$37.50M
10-Q · filed 2020-02-06
$24.63M
derived: sum of 4 quarters · filed 2020-05-08
2018-09-30$12.68M
10-K · filed 2020-05-08
$24.67M
10-Q · filed 2019-10-31
$11.80M
derived: sum of 3 quarters · filed 2020-05-08
-$245.36M
derived: sum of 4 quarters · filed 2020-05-08
2018-06-30$11.99M
10-K · filed 2020-05-08
-$881.00K
derived: sum of 2 quarters · filed 2020-05-08
-$258.04M
derived: sum of 3 quarters · filed 2020-05-08
-$239.42M
derived: sum of 4 quarters · filed 2020-05-08
2018-03-31-$12.88M
10-K · filed 2019-05-13
-$270.03M
derived: sum of 2 quarters · filed 2019-05-13
-$251.41M
derived: sum of 3 quarters · filed 2019-05-13
-$232.48M
10-K · filed 2020-05-08
2017-12-31-$257.15M
10-K · filed 2019-05-13
-$238.54M
derived: sum of 2 quarters · filed 2019-05-13
-$219.61M
10-Q · filed 2019-02-07
-$211.90M
derived: sum of 4 quarters · filed 2019-05-13
2017-09-30$18.62M
10-K · filed 2019-05-13
$37.55M
10-Q · filed 2018-11-01
$45.26M
derived: sum of 3 quarters · filed 2019-05-13
$64.35M
derived: sum of 4 quarters · filed 2019-05-13
2017-06-30$18.93M
10-K · filed 2019-05-13
$26.64M
derived: sum of 2 quarters · filed 2019-05-13
$45.73M
derived: sum of 3 quarters · filed 2019-05-13
$63.77M
derived: sum of 4 quarters · filed 2019-05-13
2017-03-31$7.71M
10-K · filed 2018-05-10
$26.80M
derived: sum of 2 quarters · filed 2018-05-10
$44.84M
derived: sum of 3 quarters · filed 2018-05-10
$41.45M
10-K · filed 2019-05-13
2016-12-31$19.09M
10-K · filed 2018-05-10
$37.13M
derived: sum of 2 quarters · filed 2018-05-10
$33.74M
10-Q · filed 2018-02-01
$44.41M
derived: sum of 4 quarters · filed 2018-05-10
2016-09-30$18.03M
10-K · filed 2018-05-10
$14.65M
10-Q · filed 2017-11-02
$25.32M
derived: sum of 3 quarters · filed 2018-05-10
$40.50M
derived: sum of 4 quarters · filed 2018-05-10
2016-06-30-$3.38M
10-K · filed 2018-05-10
$7.29M
derived: sum of 2 quarters · filed 2018-05-10
$22.47M
derived: sum of 3 quarters · filed 2018-05-10
$39.90M
derived: sum of 4 quarters · filed 2018-05-10
2016-03-31$10.67M
10-K · filed 2017-05-17
$25.85M
derived: sum of 2 quarters · filed 2017-05-17
$43.28M
derived: sum of 3 quarters · filed 2017-05-17
$57.28M
10-K · filed 2018-05-10
2015-12-31$15.19M
10-K · filed 2017-05-17
$32.61M
derived: sum of 2 quarters · filed 2017-05-17
$46.61M
10-Q · filed 2017-02-02
$60.29M
derived: sum of 4 quarters · filed 2017-05-17
2015-09-30$17.43M
10-K · filed 2017-05-17
$31.43M
10-Q · filed 2016-11-03
$45.10M
derived: sum of 3 quarters · filed 2017-05-17
$57.34M
derived: sum of 4 quarters · filed 2017-05-17
2015-06-30$14.00M
10-K · filed 2017-05-17
$27.67M
derived: sum of 2 quarters · filed 2017-05-17
$39.91M
derived: sum of 3 quarters · filed 2017-05-17
$51.78M
derived: sum of 4 quarters · filed 2017-05-17
2015-03-31$13.68M
10-K · filed 2016-05-17
$25.92M
derived: sum of 2 quarters · filed 2016-05-17
$37.78M
derived: sum of 3 quarters · filed 2016-05-17
$49.20M
10-K · filed 2017-05-17
2014-12-31$12.24M
10-K · filed 2016-05-17
$24.10M
derived: sum of 2 quarters · filed 2016-05-17
$35.52M
10-Q · filed 2016-02-04
$46.22M
derived: sum of 4 quarters · filed 2016-05-17
2014-09-30$11.86M
10-K · filed 2016-05-17
$23.28M
10-Q · filed 2015-11-05
$33.98M
derived: sum of 3 quarters · filed 2016-05-17
$35.04M
derived: sum of 4 quarters · filed 2016-05-17
2014-06-30$11.42M
10-K · filed 2016-05-17
$22.12M
derived: sum of 2 quarters · filed 2016-05-17
$23.18M
derived: sum of 3 quarters · filed 2016-05-17
$27.71M
derived: sum of 4 quarters · filed 2016-05-17
2014-03-31$10.70M
10-K · filed 2015-05-14
$11.76M
derived: sum of 2 quarters · filed 2015-05-14
$16.29M
derived: sum of 3 quarters · filed 2015-05-14
$29.13M
10-K · filed 2016-05-17
2013-12-31$1.06M
10-K · filed 2015-05-14
$5.59M
derived: sum of 2 quarters · filed 2015-05-14
$18.43M
10-Q · filed 2015-02-05
$29.57M
derived: sum of 4 quarters · filed 2015-05-14
2013-09-30$4.53M
10-K · filed 2015-05-14
$17.38M
10-Q · filed 2014-11-06
$28.52M
derived: sum of 3 quarters · filed 2015-05-14
$36.32M
derived: sum of 4 quarters · filed 2015-05-14
2013-06-30$12.84M
10-K · filed 2015-05-14
$23.99M
derived: sum of 2 quarters · filed 2015-05-14
$31.79M
derived: sum of 3 quarters · filed 2015-05-14
$44.04M
derived: sum of 4 quarters · filed 2015-05-14
2013-03-31$11.14M
10-K · filed 2014-05-19
$18.95M
derived: sum of 2 quarters · filed 2014-05-19
$31.20M
derived: sum of 3 quarters · filed 2014-05-19
$40.53M
10-K · filed 2015-05-14
2012-12-31$7.80M
10-K · filed 2014-05-19
$20.06M
derived: sum of 2 quarters · filed 2014-05-19
$29.39M
10-Q · filed 2014-02-07
$30.20M
derived: sum of 4 quarters · filed 2014-05-19
2012-09-30$12.25M
10-K · filed 2014-05-19
$21.58M
10-Q · filed 2013-11-07
$22.40M
derived: sum of 3 quarters · filed 2014-05-19
$28.40M
derived: sum of 4 quarters · filed 2014-05-19
2012-06-30$9.33M
10-K · filed 2014-05-19
$10.14M
derived: sum of 2 quarters · filed 2014-05-19
$16.15M
derived: sum of 3 quarters · filed 2014-05-19
$24.32M
derived: sum of 4 quarters · filed 2014-05-19
2012-03-31$815.00K
10-K · filed 2013-05-17
$6.82M
derived: sum of 2 quarters · filed 2013-05-17
$14.99M
derived: sum of 3 quarters · filed 2013-05-17
$23.95M
10-K · filed 2014-05-19
2011-12-31$6.00M
10-K · filed 2013-05-17
$14.18M
derived: sum of 2 quarters · filed 2013-05-17
$23.13M
10-Q · filed 2013-02-07
$26.53M
derived: sum of 4 quarters · filed 2013-05-17
2011-09-30$8.17M
10-K · filed 2013-05-17
$17.13M
10-Q · filed 2012-11-07
$20.53M
derived: sum of 3 quarters · filed 2013-05-17
$23.73M
derived: sum of 4 quarters · filed 2013-05-17
2011-06-30$8.95M
10-K · filed 2013-05-17
$12.35M
derived: sum of 2 quarters · filed 2013-05-17
$15.56M
derived: sum of 3 quarters · filed 2013-05-17
$22.61M
derived: sum of 4 quarters · filed 2013-05-17
2011-03-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-17
$6.61M
derived: sum of 2 quarters · filed 2013-05-17
$13.66M
derived: sum of 3 quarters · filed 2013-05-17
$19.35M
10-K · filed 2013-05-17
2010-12-31$3.20M
10-Q · filed 2012-02-09
$10.26M
derived: sum of 2 quarters · filed 2012-02-09
$15.95M
10-Q · filed 2012-02-09
2010-09-30$7.05M
10-Q · filed 2011-11-09
$12.74M
10-Q · filed 2011-11-09
2010-06-30$5.69M
10-Q · filed 2011-08-05
2010-03-31$20.66M
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Zai Lab Ltd (ZLAB)$2.241B-113.34
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05